Sun Pharma Advanced Research Company Ltd is finalizing a resourcing plan for FY27–FY28, involving promoter-supported debt and internal cash accruals. The strategy aims to fund R&D initiatives, strengthen financial stability, and sustain innovation. Analysts view the plan as a positive step toward long-term growth and resilience.
Show moreStay Ahead – Explore Now! India’s Auto Retail Surges 14.63% In December 2025, Outlook Remains Strong
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
